The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of single-agent adjuvant trastuzumab in older women with early-stage breast cancer.
 
Cynthia Owusu
No Relationships to Disclose
 
Seunghee P Margevicius
No Relationships to Disclose
 
Heidi D. Klepin
Consulting or Advisory Role - Genentech
Patents, Royalties, Other Intellectual Property - UptoDate contributor
(OPTIONAL) Uncompensated Relationships - Genentech
 
Charles L. Vogel
Consulting or Advisory Role - Abbvie; Abbvie; Adgero Biopharmaceuticals; Adjero; Puma Biotechnology; Puma Biotechnology
Research Funding - AstraZeneca; Briova; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunomedics; Many; Merck; Novartis; Odonate Therapeutics; Pfizer; Seagen
Expert Testimony - Genentech; Genentech; Novartis; Novartis
Travel, Accommodations, Expenses - Abbvie; Abbvie; Puma Biotechnology; Puma Biotechnology
 
Asrar Alahmadi
No Relationships to Disclose
 
Sowjanya Vuyyala
No Relationships to Disclose
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Bayer; Bioarray Therapeutics; bioTheranostics; Celgene; Eisai; Genentech/Roche; Genomic Health; Lilly; Merck; Myriad Pharmaceuticals; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology